Cronos Group Reports 2022 Second Quarter Results
August 09, 2022 07:30 ET
|
Cronos Group Inc.
Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022 Israel net revenue increased by 212% year-over-year to $7.2 million in Q2 2022 Announced achievement of THCV...
Cronos Group Inc. to Hold 2022 Second Quarter Earnings Conference Call on August 9, 2022
July 13, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 second quarter earnings conference call on Tuesday, August 9,...
Cronos Group Partners with Geocann to Leverage VESIsorb® Delivery Technology for Faster Absorption
June 27, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is pleased to announce the launch of the first of what is expected to be a range...
Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders
June 24, 2022 16:05 ET
|
Cronos Group Inc.
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the...
Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
June 21, 2022 07:00 ET
|
Cronos Group Inc.
TORONTO and BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”),...
Cronos Group Inc. Announces Conference Participation for May 2022
May 10, 2022 16:15 ET
|
Cronos Group Inc.
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike...
Cronos Group Reports 2022 First Quarter Results
May 10, 2022 07:30 ET
|
Cronos Group Inc.
Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022 Israel net revenue increased by 263% year-over-year to $9.1 million in Q1 2022 Increased market share in Canada...
Cronos Group Inc. to Hold Virtual 2022 Annual Meeting of Shareholders
April 29, 2022 10:00 ET
|
Cronos Group Inc.
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2022 Annual Meeting of Shareholders on Thursday, June 23,...
Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022
April 25, 2022 16:30 ET
|
Cronos Group Inc.
TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 first quarter earnings conference call on Tuesday, May 10,...
Cronos Group Founder Mike Gorenstein Returns as CEO
March 21, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that the Board of...